Macular edema in Vogt-Koyanagi-Harada syndrome treated with antiangiogenic therapy. Case report

50% of patients with syndrome Vogt-Koyanagi-Harada presents ocular complications, 5-10% have neovascular membrane and macular edema. We present a 39-year-old woman with macular edema secondary to syndrome Vogt-Koyanagi-Harada, treated with antiangiogenic intravitreal injections and its evolution was objectively followed with optical coherence tomography. Discussion: Antiangiogenic intravitreal injections are an alternative for the treatment of macular edema secondary to inflammatory eye diseases compared to conventional therapy with sub-Tenon steroids and intravitreal injections.